Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Operating Leases (2023 - 2025)

Rallybio (RLYB) has disclosed Operating Leases for 3 consecutive years, with $176000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases changed N/A to $176000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $176000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $176000.0 for FY2025, N/A changed from the prior year.
  • Operating Leases hit $176000.0 in Q4 2025 for Rallybio, up from $108000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $321000.0 in Q1 2023 to a low of $58000.0 in Q2 2024.
  • Historically, Operating Leases has averaged $178625.0 across 3 years, with a median of $174500.0 in 2023.
  • Biggest YoY gain for Operating Leases was 63.86% in 2024; the steepest drop was 78.2% in 2024.
  • Year by year, Operating Leases stood at $173000.0 in 2023, then crashed by 66.47% to $58000.0 in 2024, then surged by 203.45% to $176000.0 in 2025.
  • Business Quant data shows Operating Leases for RLYB at $176000.0 in Q4 2025, $108000.0 in Q3 2025, and $58000.0 in Q2 2024.